External Event - 28th to 29th Sep 2017
Exploring cutting-edge technologies in pre-clinical neuroscience studies
Radisson Blu Edwardian Heathrow Hotel
28th - 29th September 2017, London, UK
Event Overview
Translation from pre-clinical neuroscience to clinical setting is one of the major setback for the researchers working in Neuroscience R&D. However, considering the recent advances in this field there have been newer technologies coming up in the area of Drug target validation, Neuroimaging, Optogenetics, Neuromodulation and Neuroinformatics using different animal models and approaches. After our two successful editions, MarketsandMarkets is proud to announce the 3rd Annual Neuroscience R&D Technologies Conference to be held on 28th-29th September 2017 in London, UK. The conference aims to focus on sharing the current market trends, technological advancements and future challenges in the pre-clinical neuroscience research where the leading experts from the pharma industry and research institutes will discuss about the latest technologies in Neuroscience R&D by presenting expert keynote presentations, live case studies and breakthrough panel discussions.
Key Highlights:
• Drug target validation technologies in CNS drug discovery
• Translational Imaging technologies-EEG, EMG, FMRI for assessment of CNS function
• Optogenetic tools used in brain mapping
• Novel neuroprostheses and neuromodulation for treating CNS disorders
• Translational animal models for CNS disorders
• Neuroinformatics and Computational Neuroscience
For more information please contact Mahvish at
mahvish.anwar@marketsandmarkets.com or visit http://www.mnmconferences.com/3rd-Annual-Neuroscience-R-D-Technologies-Conference
